News
NIH renews Baylor College of Medicine grant for Human Microbiome Project program at Texas Children's Hospital
September 7, 2010 2:33 pm | by Baylor College of Medicine | CommentsThe National Institutes of Health today announced expanded funding of the Baylor College of Medicine Human Microbiome Project clinical program initiated last year at Texas Children's Hospital . The program will receive $3.4 million over three years to broaden the current study of...
Sparks Will Fly at Weld Trials Competition at 2010 FABTECH Show in Atlanta
September 7, 2010 10:39 am | by Society of Manufacturing Engineers | CommentsMIAMI, FLA., September 2, 2010 — The top six finalists selected from 24 student welders that competed in the SkillsUSA Championships 2009 and 2010 will be showcased at the 2010 Weld-Off Competition sponsored by the American Welding Society at the FABTECH show Nov. 2-4, in Atlanta. More
Reportlinker Adds Hypertension: Competing Treatments and Market Entry Considerations
September 7, 2010 10:35 am | by Bio-Medicine.Org | CommentsNEW YORK, Sept. 7 /- Reportlinker.com announces that a new market research report is available in its catalogue: Hypertension: Competing Treatments and Market Entry Considerations http://www.reportlinker.com/p0287870/Hypertension-Competing-Treatments-a......
Reportlinker Adds Drug Delivery in Central Nervous System Diseases - technologies,markets and companies
September 7, 2010 10:35 am | by Bio-Medicine.Org | CommentsNEW YORK, Sept. 7 /- Reportlinker.com announces that a new market research report is available in its catalogue: Drug Delivery in Central Nervous System Diseases - technologies,markets and companies...
Reportlinker Adds Cell Therapy - Technologies, Markets and Companies
September 7, 2010 10:35 am | by Bio-Medicine.Org | CommentsNEW YORK, Sept. 7 /- Reportlinker.com announces that a new market research report is available in its catalogue: Cell Therapy - Technologies, Markets and Companies http://www.reportlinker.com/p0203537/Cell-Therapy---Technologies-Markets... SummaryThis report describes and...
Will MHLW Changes in Reimbursement Drive Japanese Physicians to Increase Usage of Chronic Dialysis Catheters?
September 7, 2010 10:34 am | by Bio-Medicine.Org | CommentsTORONTO, Sept. 7 /- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, changes in Japan's Ministry of Health Labour and Welfare (MHLW) reimbursement, which encourage facilities to use higher-priced chronic dialysis catheters, will...
BCM Human Genome Sequencing Center joins NIH's Pharmacogenomics Research Network
September 7, 2010 10:33 am | by Baylor College of Medicine | CommentsThe Baylor College of Medicine Human Genome Sequencing Center has received a five-year, $2.3 million grant to join the National Institutes of Health's Pharmacogenomics Research Network , a collaborative project that seeks to advance research on how genes affect people's responses to a...
Kahn Swick & Foti, LLC and Former Louisiana Attorney General Announce Class Complaint Against Beckman Coulter, Inc. on Behalf of Shareholders Who Purchased Shares of BEC From July ...
September 7, 2010 9:45 am | by The Associated Press | CommentsKahn Swick & Foti, LLC ("KSF") (www.ksfcounsel.com (http://www.ksfcounsel.com) ), a nationally recognized Louisiana-based law firm, and KSF partner Charles C. Foti, Jr., former Attorney General of Louisiana, announce that a class action securities case was filed in the United States...
Medtronic says EU clears new CoreValve system
September 7, 2010 8:45 am | by The Associated Press | CommentsMedtronic Inc. said Tuesday that regulators in the European Union have approved the latest version of its CoreValve heart system.The CoreValve delivery system is designed to help surgeons replace a diseased aortic valve without taking out the original valve and without open heart surgery....
James F. Szigethy Named Curemark's Director of New Product Development
September 7, 2010 8:36 am | by Bio-Medicine.Org | CommentsRYE, N.Y., Sept. 7 /- Curemark ( www.curemark.com ), a drug research and development company focused on the treatment of neurological diseases, announced that James F. Szigethy, formerly a consultant for Curemark, has assumed the position of Director of New Product Development. In...
Varian Medical Systems Develops New X-Ray Tube for Use in Security Scanning Systems
September 7, 2010 8:35 am | by Bio-Medicine.Org | CommentsSALT LAKE CITY, Sept. 7 /- Varian Medical Systems, Inc. (NYSE: VAR ), has developed a new X-ray tube designed to operate in security systems capable of generating high resolution detailed images needed to detect threats in airports, military bases, prisons, and other secured facilities....
Study finds more Americans bypassing their personal physician when immediate treatment required
September 7, 2010 8:34 am | by EurekAlert | Comments(Emory University) Only 45 percent of the 354 million annual visits for acute care in the United States are made to patients' personal physicians, as Americans increasingly make busy emergency departments, specialists or outpatient care departments their first point of contact for...
Experts recommend universal screening of newborns for congenital adrenal hyperplasia
September 7, 2010 8:33 am | by EurekAlert | Comments(The Endocrine Society) Today, the Endocrine Society released a new clinical practice guideline on the diagnosis and treatment of congenital adrenal hyperplasia. The guideline features a series of evidence-based clinical recommendations developed by an expert task force.
NetMotion Wireless Tapped by IDEXX Laboratories to Provide Secure Mobile Access to Field Personnel
September 7, 2010 6:35 am | by Bio-Medicine.Org | CommentsSEATTLE, Sept. 7 /- NetMotion Wireless, a leading provider of mobile productivity and management software, announced today that its award winning mobile Virtual Private Network (VPN) solution, Mobility XE, has been deployed by IDEXX to improve the performance of hundreds of mobile workers...
MAP Pharmaceuticals to Present at Upcoming Healthcare and Scientific Conferences
September 7, 2010 6:35 am | by Bio-Medicine.Org | CommentsMOUNTAIN VIEW, Calif., Sept. 7 /- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced that the Company will participate in the following healthcare conferences in September: Morgan Stanley Global Healthcare Conference Tuesday, September 14, at 11:30 a.m. ET in New York Stifel...
